Amgen Files 2025 Annual Report to Security Holders
Ticker: AMGN · Form: ARS · Filed: Mar 31, 2026 · CIK: 0000318154
Sentiment: neutral
Topics: annual-report, sec-filing, financials
TL;DR
Amgen filed its 2025 ARS on 3/31/26. Check it for full year performance.
AI Summary
Amgen Inc. filed its Annual Report to Security Holders (ARS) on March 31, 2026, for the period ending December 31, 2025. The report details the company's financial performance and operations for the fiscal year 2025. Amgen Inc. is headquartered in Thousand Oaks, California.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of Amgen's performance and strategic direction for the past fiscal year, influencing investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing providing historical financial information and does not indicate any immediate new risks.
Key Numbers
- 2025-12-31 — Fiscal Year End (Period covered by the ARS filing)
- 2026-03-31 — Filing Date (Date the ARS was officially submitted to the SEC)
Key Players & Entities
- Amgen Inc. (company) — Filer
- 0000318154 (company) — CIK
- 2026-03-31 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
- ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (address) — Mailing and Business Address
FAQ
What is the primary purpose of an ARS filing?
An ARS filing, or Annual Report to Security Holders, provides shareholders with a comprehensive overview of the company's financial performance and activities for the past fiscal year.
What period does this specific ARS filing cover?
This ARS filing from Amgen Inc. covers the period ending December 31, 2025.
When was this ARS filing accepted by the SEC?
This ARS filing was accepted by the SEC on March 31, 2026.
Where is Amgen Inc. headquartered?
Amgen Inc. is headquartered at ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA 91320.
What is Amgen Inc.'s CIK number?
Amgen Inc.'s CIK (Central Index Key) number is 0000318154.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on March 31, 2026 regarding AMGEN INC (AMGN).